Detecting Laryngeal Lesions with MCM Proteins
Author Information
Author(s): Chatrath P, Scott I S, Morris L S, Davies R J, Rushbrook S M, Bird K, Vowler S L, Grant J W, Saeed I T, Howard D, Laskey R A, Coleman N
Primary Institution: MRC Cancer Cell Unit, Hutchison/MRC Research Centre
Hypothesis
Can minichromosome maintenance proteins (MCMs) improve the detection of laryngeal dysplasia and carcinoma?
Conclusion
The study suggests that MCM-2 is a promising biomarker for identifying premalignant and malignant laryngeal lesions.
Supporting Evidence
- MCM-2 expression was significantly higher in dysplastic lesions compared to normal laryngeal tissue.
- Immunocytochemical analysis of laryngeal brushings showed MCM-2 positivity in malignant cases.
- Double-labelling confocal microscopy revealed co-expression of MCM-2 and Ki67 in laryngeal lesions.
Takeaway
Researchers found that a special protein called MCM-2 can help doctors find early signs of throat cancer by looking at cells from the throat.
Methodology
The study used immunocytochemical staining and double-labelling confocal microscopy to analyze laryngeal specimens.
Potential Biases
Potential bias in observer interpretation of immunocytochemical staining results.
Limitations
The study was limited by the small sample size and the need for general anesthesia for laryngeal examination.
Participant Demographics
Participants included patients undergoing laryngeal biopsy for suspicious lesions.
Statistical Information
P-Value
0.001
Confidence Interval
[0.84, 0.97]
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website